Iron age: novel targets for iron overload.
暂无分享,去创建一个
[1] S. Rivella,et al. Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia. , 2014, Blood.
[2] S. Rivella,et al. β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis. , 2014, The international journal of biochemistry & cell biology.
[3] S. Rivella,et al. IDENTIFICATION OF ERYTHROFERRONE AS AN ERYTHROID REGULATOR OF IRON METABOLISM , 2014, Nature Genetics.
[4] T. Papayannopoulou,et al. Stage-specific functional roles of integrins in murine erythropoiesis. , 2014, Experimental hematology.
[5] S. Rivella,et al. Modulators of erythropoiesis: emerging therapies for hemoglobinopathies and disorders of red cell production. , 2014, Hematology/oncology clinics of North America.
[6] A. Fricot,et al. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia , 2014, Nature Medicine.
[7] S. Rivella,et al. Intestinal HIF2α promotes tissue-iron accumulation in disorders of iron overload with anemia , 2013, Proceedings of the National Academy of Sciences.
[8] S. Rivella,et al. Treatment With Minihepcidin Peptide Improves Anemia and Iron Overload In a Mouse Model Of Thalassemia Intermedia , 2013 .
[9] M. Fleming,et al. An RNAi-Therapeutic Targeting Tmprss6, in Conjunction With Oral Chelator Therapy, Ameliorates Anemia and Additively Diminishes Secondary Iron Overload In a Mouse Model Of β-Thalassemia Intermedia , 2013 .
[10] D. Bowden,et al. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study. , 2013, Blood.
[11] S. Rivella,et al. Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice. , 2013, The Journal of clinical investigation.
[12] S. Rivella,et al. Macrophages support pathological erythropoiesis in Polycythemia Vera and Beta-Thalassemia , 2013, Nature Medicine.
[13] S. Milstein,et al. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia. , 2013, Blood.
[14] T. Ganz,et al. Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. , 2012, Blood.
[15] Elizabeta Nemeth,et al. Hepcidin and iron homeostasis. , 2012, Biochimica et biophysica acta.
[16] M. Lidonnici,et al. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia. , 2012, Blood.
[17] S. Rivella. The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia. , 2012, Blood reviews.
[18] Elizabeta Nemeth,et al. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. , 2011, The Journal of clinical investigation.
[19] S. Rivella,et al. β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. , 2011, Blood.
[20] S. Rivella,et al. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. , 2010, The Journal of clinical investigation.
[21] Baskar Ramdas,et al. Essential role for focal adhesion kinase in regulating stress hematopoiesis. , 2010, Blood.
[22] D. Koeberl,et al. The Role of Hepatocyte Hemojuvelin in the Regulation of Bone Morphogenic Protein-6 and Hepcidin Expression in Vivo* , 2010, The Journal of Biological Chemistry.
[23] Charles B. Hall,et al. Transferrin therapy ameliorates disease in β-thalassemic mice , 2010, Nature Medicine.
[24] P. Brissot. Les hémochromatoses. Nouvelle compréhension, nouveaux traitements , 2009 .
[25] S. Rivella. Ineffective erythropoiesis and thalassemias , 2009, Current opinion in hematology.
[26] Jerry Kaplan,et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.
[27] S. Rivella,et al. Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia. , 2008, Blood.
[28] N. Andrews,et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.
[29] N. Andrews,et al. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. , 2007, Blood.
[30] T. Ganz,et al. Suppression of hepcidin during anemia requires erythropoietic activity. , 2006, Blood.
[31] Yi Fang Liu,et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. , 2006, Blood.
[32] Raymond T Chung,et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.
[33] G. Pinkus,et al. A mouse model of juvenile hemochromatosis. , 2005, The Journal of clinical investigation.
[34] N. Andrews,et al. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. , 2005, The Journal of clinical investigation.
[35] R. Paulson,et al. BMP4 and Madh5 regulate the erythroid response to acute anemia. , 2005, Blood.
[36] Gaël Nicolas,et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. , 2002, The Journal of clinical investigation.
[37] C. Beaumont,et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[38] C. Beaumont,et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Stockman. Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice , 2013 .
[40] P. Brissot. [Haemochromatoses. New understanding, new treatments]. , 2009, Gastroenterologie clinique et biologique.
[41] Matthias W. Hentze,et al. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004 .